A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. 1981

H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
February 1991, Chronobiology international,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
December 1985, Life sciences,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
March 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
January 1985, Biopharmaceutics & drug disposition,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
March 2006, Birth defects research. Part A, Clinical and molecular teratology,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
February 1993, Biological trace element research,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
August 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
December 2016, The journal of trauma and acute care surgery,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
June 1990, Biological trace element research,
H Nau, and R Zierer, and H Spielmann, and D Neubert, and C Gansau
January 2012, Current medicinal chemistry,
Copied contents to your clipboard!